Pa. doctor convicted for allegedly giving patients illegal drug ‘goody bags'
According to court documents, 48-year-old Neil K. Anand M.D., of Bensalem conspired to submit false claims to Medicare, health plans provided by the U.S. Office of Personnel Management (OPM), Independence Blue Cross (IBC), and Anthem, for 'goody bags' of medically unnecessary prescription medications, which were given to patients from an in-house pharmacies owned by Anand.
The US Department of Justice stated that patients were required to take the 'goody bags', which they did not need or want, to receive prescriptions for controlled substances.
In total, Medicare, OPM, IBC, and Anthem paid over $2.3 million for the Goody Bags.
Man accused of hiding camera inside bathroom smoke detector
Authorities say Anand also conspired to give oxycodone without a legitimate medical purpose and, as part of the scheme, Anand prescribed 20,850 oxycodone tablets for nine different patients.
After learning that he was under investigation, investigators said Anand concealed the proceeds of the fraud by transferring around $1.2 million into an account that had his father's name and was for the benefit of his daughter.
Anand was convicted of conspiracy to commit health care fraud and wire fraud, money laundering, unlawful monetary transactions, and conspiracy to distribute controlled substances.
He is scheduled to be sentenced on August 19 and faces a maximum penalty of 130 years in prison.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Michael Burry is Betting Big on This 1 S&P 500 Stock That's Down 40% in 2025
Michael Burry, the legendary investor famous for predicting the 2008 housing crisis, has taken a new position in UnitedHealth Group (UNH) through his Scion Asset Management, according to 13F filings for the second quarter. UnitedHealth stock has been battered in 2025, falling nearly 60% from all-time highs through last Thursday before surging 12% on Friday, Aug. 15 following Warren Buffett's surprise disclosure of a $1.6 billion stake. The healthcare giant has faced intense scrutiny as the poster child for America's rising healthcare costs. More News from Barchart As SoFi Launches International Money Transfer Services, How Should You Play SOFI Stock? This Cannabis Stock Just Transformed Into a Bitcoin Treasury Play. Should You Buy Shares Now? Profiting from Volatility: CRWV Long Straddle Trade Setup Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! The nation's largest private health insurer is navigating multiple headwinds. CEO Andrew Witty stepped down in May after the company pulled its annual earnings outlook. A Justice Department investigation into Medicare billing practices has added regulatory pressure, while the company's revised 2025 outlook fell well short of Wall Street expectations. Burry's investment suggests he sees opportunity amid the turmoil. This adds on to Buffett's investment, which analysts say 'represents a big vote of confidence' and could provide a 'trading floor' for the managed care sector. With UnitedHealth trading at deeply discounted levels despite its market-leading position, contrarian investors like Burry may be betting the current challenges are temporary while the long-term healthcare demand thesis remains intact. Is UNH Stock a Good Buy Right Now? UnitedHealth Group's Q2 earnings call revealed near-term pressures, but also highlighted compelling reasons why the healthcare giant could emerge stronger for long-term investors. UnitedHealth's medical costs have been rising faster than expected. The company initially estimated costs to go up about 7.5% this year, but they're actually rising even more. For 2026, UnitedHealth is being much more conservative and assuming medical costs will rise by nearly 10%. The company is responding by: Raising prices - Charging higher premiums to customers to cover the increased medical costs. Cutting benefits - Reducing what services insurance plans will cover or making customers pay more out of pocket. Using narrower networks - Limiting which doctors and hospitals customers can use (typically to cheaper, more efficient providers). These changes take time to work through the system. Most of UnitedHealth's contracts renew on Jan. 1, so the 2026 changes will start helping their profits next year, with full benefits showing up by 2027. CEO Stephen Hemsley has initiated comprehensive operational reforms, including monthly business reviews, enhanced forecasting processes, and significant management changes across Optum. Moreover, UNH is investing heavily in AI capabilities and modernizing its technology stack, which should drive long-term efficiency gains. Despite execution challenges, OptumHealth's value-based care model continues to demonstrate superior outcomes with 20% fewer hospitalizations and 11% fewer ER visits versus. Mature patient cohorts (2021 and prior) are achieving 8%-plus margins, proving the model's viability once properly executed. UNH stock remains the dominant player in multiple healthcare segments with unmatched scale advantages. Its integrated model combining insurance, pharmacy benefits, and care delivery creates defensive moats that competitors struggle to replicate. What Is the Target Price for UNH Stock? Analysts tracking UNH stock forecast adjusted net income to expand from an estimated $16.24 per share in 2025 to $32.22 per share in 2029. Today, UNH stock trades at a forward price-earnings multiple of 19x, which is in line with the 10-year average. If it trades at a similar multiple, the healthcare stock should trade around $608 in early 2029, indicating an upside potential of over 100% from current levels. Out of the 25 analysts covering UNH stock, 15 recommend 'Strong Buy,' two recommend 'Moderate Buy,' six recommend 'Hold,' and two recommend 'Strong Sell.' The average UNH stock price target is $306.62, roughly in line with the current trading price. On the date of publication, Aditya Raghunath did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
By Jonathan Stempel (Reuters) -A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs. In a Tuesday decision, Chief Judge Mitchell Goldberg in Philadelphia federal court tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the federal False Claims Act. He added a $4.87 million civil fine. Goldberg rejected CVS' request to pay less, saying that while CVS Caremark was liable for only two years of overbilling, evidence at trial "made clear that the fraud was financially motivated, not the result of some innocent or mistaken belief." CVS, based in Woonsocket, Rhode Island, said on Wednesday it plans to appeal. Last month, a Manhattan federal judge ordered CVS' Omnicare unit to pay $948.8 million in a separate whistleblower lawsuit alleging fraudulent billing. CVS plans to appeal that judgment. Goldberg presided in March over a non-jury trial in the whistleblower case brought by Sarah Behnke, a former head actuary for Medicare Part D at Aetna. She accused CVS Caremark of having caused health insurers such as Aetna to submit inflated claims since 2010 to the Centers for Medicare and Medicaid Services (CMS), while pharmacies such as Rite Aid and Walgreens were paid less. CVS argued that the original $95 million in damages was substantial, and punitive damages should be limited to $95 million. But the judge said CVS Caremark's fraud not only financially harmed the government, but diminished public confidence in it. "CMS relies on companies like Caremark to truthfully and accurately report Part D drug prices," he wrote. "Caremark's conduct broke CMS's trust, and as a result, the public's trust in CMS." Behnke sued in 2014. CVS bought Aetna four years later. The False Claims Act lets whistleblowers sue on behalf of the government and share in recoveries, typically 15% to 30%. The case is US ex rel Behnke v CVS Caremark Corp et al, U.S. District Court, Eastern District of Pennsylvania, No. 14-00824.
USA Today
4 hours ago
- USA Today
If you live in these states, your health care won't be as big or beautiful
Democratic-leaning states will feel more of the impact of sweeping Medicaid cuts included in the One Big Beautiful Bill Act, according to a new analysis by Oxford Economics. The report, authored by lead economist Barbara Denham, says that millions of Americans – regardless of where they live – will lose access to health insurance because of the tighter eligibility rules and new work requirements. Immigrants will be disproportionately affected, with many losing coverage under Medicaid, Medicare and the Children's Health Insurance Program. States such as California and New York – which have both expanded Medicaid and have large immigrant populations – are expected to be hit hardest. Other vulnerable states with large immigrant populations include Louisiana, Nevada, New Jersey, New Mexico and Washington, D.C. 'Federal funding cuts and the expiration of the Marketplace subsidies will have several economic consequences,' Denham wrote. 'The number of newly uninsured will rise significantly, putting more at risk of worse long-term well-being, which will sap productivity growth' States with the highest percentage of residents enrolled in Medicaid Unable to view our graphics? Click here to see them. The new law limits federal matching funds for noncitizens' medical care, shifting the financial burden to state governments and hospitals. That's particularly concerning for states with high percentages of foreign-born residents, many of whom rely on Medicaid. The federal cuts to Medicaid funding come at a time when states are looking to trim their spending, too. The Kaiser Family Foundation recently reported California has paused enrolling new immigrants in its health coverage program while Illinois has stopped state-funded health benefits for all immigrant adults between 42 to 64. States such as Idaho and Tennessee also enacted legislation limiting immigrant access to state health care benefits. States with the highest percentage of foreign-born residents Since 2012, 40 states and the District of Columbia have expanded Medicaid under federal initiatives. But with the expiration of marketplace subsidies and new restrictions on immigrant coverage, a handful of states now face the steepest declines in federal health care funding. Based on Oxford Economics' analysis of Congressional Budget Office and KFF data, more left-leaning states will lose more money per resident as the new law rolls out, but right-leaning Louisiana stands to lose the most ($5,855 per resident) of any state. Alabama, Florida, Georgia, South Carolina and Wyoming – states that didn't expand their Medicaid benefits – will see some of the smallest cuts. How much Medicaid funding each state is projected to lose per resident Some states have passed laws to buffer their residents or their budgets against federal cuts. For example: ◾ Their residents: New York, Missouri, Oklahoma, and South Dakota require coverage for adults earning up to 138% of the federal poverty line. ◾ Their budgets: Arizona, Arkansas, Illinois, Indiana, Montana, New Hampshire, North Carolina, Utah and Virginia tie Medicaid spending to federal funding levels.
